Literature DB >> 7011992

Respective contributions to protection of primary and booster immunization with Escherichia coli heat-labile enterotoxin in rats.

F A Klipstein, R F Engert.   

Abstract

The respective contributions to protection of the route and dosage of primary and booster immunizations with Escherichia coli heat-labile enterotoxin were evaluated in rats. The degree of protection was determined by challenge with toxin and viable bacteria in ligated ileal loops, and the serum antitoxin response was assayed by enzyme-linked immunosorbent assay. Primary immunization was effective only when given by the parenteral route. The degree of protection was enhanced a fivefold dosage increase in the primary parenteral immunization in rats given constant dosages of booster immunizations either parenterally or perorally, but not by further dosage increases. In contrast, the degree of protection rose when dosages of the booster immunizations were increased over a 25-fold range. Four weekly peroral, but only two biweekly parenteral, booster immunizations were necessary to achieve strong protection; biweekly combined parenteral and peroral booster immunizations yielded both strong, immediate and extended protection. The degree of protection against the toxin correlated with that against viable bacteria and with elevated serum antitoxin titers: all seven groups with a protection index of greater than 5 against the toxin had strong protection against heat-labile toxin-producing strains and fourfold or greater increases in the antitoxin titers, whereas none of the nine groups with a protection index of less than 3 was protected against bacteria or had an equivalent antitoxin response. These observations show that once an adequate parenteral primary immunization is given, the degree of protection is influenced primarily by the dosage of the booster immunizations, the necessary number of which is dependent on their route of administration.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7011992      PMCID: PMC351777          DOI: 10.1128/iai.31.1.252-260.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

1.  STUDIES ON THE GRAM-NEGATIVE CELL WALL. I. EVIDENCE FOR THE ROLE OF 2-KETO- 3-DEOXYOCTONATE IN THE LIPOPOLYSACCHARIDE OF SALMONELLA TYPHIMURIUM.

Authors:  M J OSBORN
Journal:  Proc Natl Acad Sci U S A       Date:  1963-09       Impact factor: 11.205

2.  Synergistic protective effect in rabbits of immunization with Vibrio cholerae lipopolysaccharide and toxin/toxoid.

Authors:  A M Svennerholm; J Holmgren
Journal:  Infect Immun       Date:  1976-03       Impact factor: 3.441

3.  The molecular nature of heat-labile enterotoxin (LT) of escherichia coli.

Authors:  W S Dallas; S Falkow
Journal:  Nature       Date:  1979-02-01       Impact factor: 49.962

4.  Protection against experimental cholera by antitoxin.

Authors:  N F Pierce; E A Kaniecki; R S Northrup
Journal:  J Infect Dis       Date:  1972-12       Impact factor: 5.226

5.  Priming and suppression of the intestinal immune response to cholera toxoid/toxin by parenteral toxoid in rats.

Authors:  N F Pierce; F T Koster
Journal:  J Immunol       Date:  1980-01       Impact factor: 5.422

6.  Antitoxic immunity in experimental cholera: protection, and serum and local antibody responses in rabbits after enteral and parenteral immunization.

Authors:  J Holmgren; A M Svennerholm; O Ouchterlony; A Anderson; G Walletström; U Westerberg-Berndtsson
Journal:  Infect Immun       Date:  1975-12       Impact factor: 3.441

7.  Antitoxic immunity to cholera in dogs immunized orally with cholera toxin.

Authors:  N F Pierce; W C Cray; P F Engel
Journal:  Infect Immun       Date:  1980-02       Impact factor: 3.441

8.  Polymyxin B-Induced Release of Low-Molecular-Weight, Heat-Labile Enterotoxin from Escherichia coli.

Authors:  D J Evans; D G Evans; S L Gorbach
Journal:  Infect Immun       Date:  1974-11       Impact factor: 3.441

9.  Induction of a mucosal antitoxin response and its role in immunity to experimental canine cholera.

Authors:  N F Pierce; W C Cray; B K Sircar
Journal:  Infect Immun       Date:  1978-07       Impact factor: 3.441

10.  Cellular kinetics of the intestinal immune response to cholera toxoid in rats.

Authors:  N F Pierce; J L Gowans
Journal:  J Exp Med       Date:  1975-12-01       Impact factor: 14.307

View more
  6 in total

1.  Combined parenteral and oral immunization results in an enhanced mucosal immunoglobulin A response to Shigella flexneri.

Authors:  D F Keren; R A McDonald; J L Carey
Journal:  Infect Immun       Date:  1988-04       Impact factor: 3.441

2.  Effect of parenteral immunization on the local immunoglobulin A response of the intestine to Shigella flexneri antigens.

Authors:  D F Keren; P J Scott; R A McDonald; M Wiatrak
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

3.  A completely synthetic toxoid vaccine containing Escherichia coli heat-stable toxin and antigenic determinants of the heat-labile toxin B subunit.

Authors:  R A Houghten; R F Engert; J M Ostresh; S R Hoffman; F A Klipstein
Journal:  Infect Immun       Date:  1985-06       Impact factor: 3.441

4.  Development of a vaccine of cross-linked heat-stable and heat-labile enterotoxins that protects against Escherichia coli producing either enterotoxin.

Authors:  F A Klipstein; R F Engert; J D Clements
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

5.  Arousal of mucosal secretory immunoglobulin A antitoxin in rats immunized with Escherichia coli heat-labile enterotoxin.

Authors:  F A Klipstein; R F Engert; J D Clements
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441

6.  Protective effect of immunization of rats with holotoxin or B subunit of Escherichia coli heat-labile enterotoxin.

Authors:  F A Klipstein; R F Engert
Journal:  Infect Immun       Date:  1981-01       Impact factor: 3.441

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.